Generated by Meeveem AI
"A global leader in genomics and human health transforming precision medicine through DNA sequencing"
Illumina develops DNA sequencing and array-based technologies that enable research discovery and personalised health. Its next-generation sequencing platforms and microarray solutions are used worldwide to study genetic variation, diagnose diseases, and develop treatments. The company's products power breakthroughs in oncology, genetic disorders, infectious diseases, reproductive health, and agriculture. Founded in 1998 and headquartered in San Diego, Illumina operates in 165 countries and generates the majority of the world's sequencing data. The company serves research institutions, hospitals, pharmaceutical companies, and clinical laboratories seeking to make genomic technology accessible for precision health.
9000
Team Members
1998
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where genomic testing is integrated into everyday healthcare, enabling early disease detection, personalised treatment, and preventive medicine for all people, regardless of geography or circumstance.
At Illumina, our mission is to unlock the power of the genome to improve human health for all.